Uday Kompella is Director at Ocugen, Inc. (OCGN). They have made 8 open-market trades across 1 company since 2021, most recently 2021-11-02.
CIK 0001791821
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OCGN | 154,416 | $124K |
Shares reported on the most recent Form 4, priced at the 2021-11-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCGN | SELL | 2021-11-01 | 2021-11-03 | $15.36 | $1.2M | -25.5% | -48.3% | -65.3% |
| OCGN | SELL | 2021-10-25 | 2021-10-27 | $9.71 | $1.1M | +2.1% | -31.6% | -64.2% |
| OCGN | SELL · 10b5-1 | 2021-10-21 | 2021-10-22 | $9.01 | $17K | +54.1% | -8.3% | -56.9% |
| OCGN | SELL | 2021-10-18 | 2021-10-20 | $8.42 | $1.7M | +59.2% | -12.1% | -54.4% |
| OCGN | SELL | 2021-07-30 | 2021-07-30 | $6.81 | $68K | +16.2% | +7.2% | +54.5% |
| OCGN | SELL | 2021-06-25 | 2021-06-25 | $8.13 | $163K | -11.0% | -19.1% | -9.7% |
| OCGN | SELL | 2021-05-28 | 2021-06-01 | $8.82 | $127K | -23.6% | -5.7% | -12.4% |
| OCGN | SELL | 2021-04-30 | 2021-05-03 | $14.02 | $982K | -40.5% | -31.7% | -50.5% |
| OCGN | SELL | 2021-04-26 | 2021-04-28 | $11.70 | $8.2M | -7.5% | -20.6% | -37.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.